V. Bubien

发表

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jaana M. Hartikainen, W. Chung, 2019, Nature Genetics.

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

F. Révillion, Chloé-Agathe Azencott, N. Sevenet, 2020, BMC Medical Research Methodology.

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

E. Schröck, C. Lázaro, G. Capellá, 2020, European Journal of Human Genetics.

Ovarian Clear Cell Carcinoma in Cowden Syndrome.

G. MacGrogan, P. Pujol, J. Tinat, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Long clinical benefit achieved in two patients with malignant paraganglioma treated by metronomic cyclophosphamide.

A. Italiano, V. Bubien, C. Dupin, 2014, Future oncology.

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

A. Whittemore, L. Kiemeney, S. Cross, 2016, Nature Communications.

PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.

V. Brouste, G. MacGrogan, N. Sevenet, 2022, Cancer genetics.

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

F. Révillion, R. Lidereau, N. Sevenet, 2021, American journal of human genetics.

High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome

V. Brouste, N. Sevenet, B. Gilbert-Dussardier, 2013, Journal of Medical Genetics.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Genetics.

Insertion of Alu elements at a PTEN hotspot in Cowden syndrome

P. Couzigou, N. Sevenet, E. Barouk-Simonet, 2017, European Journal of Human Genetics.

Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium

C. Houdayer, T. Frebourg, C. Toulas, 2021, Clinical genetics.

Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study

E. Letouzé, G. MacGrogan, N. Sevenet, 2017, Genes, chromosomes & cancer.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2021, Nature Communications.

Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predisposition

N. Sevenet, J. Tinat, L. Venat-Bouvet, 2022, Journal of Human Genetics.

TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing

J. Lemonnier, N. Sevenet, D. Stoppa-Lyonnet, 2021, Cancers.

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Jane E. Carpenter, W. Chung, M. Beckmann, 2019, npj Breast Cancer.

Ovarian Clear Cell Carcinoma in Cowden Syndrome.

G. MacGrogan, P. Pujol, J. Tinat, 2019, The Journal of the National Comprehensive Cancer Network.